Rubicon Research IPO Lists Today: 20% Gains Expected
Rubicon Research’s initial public offering makes its stock market debut on NSE and BSE today, October 16, with analysts predicting strong listing gains of up to 20% over the issue price.
Key Takeaways
- IPO listing date: October 16 on NSE & BSE
- Expected listing gain: 20% over upper price band of ₹485
- Grey market premium: ₹96 indicating strong investor demand
- Issue size: ₹1,377 crore
The ₹1,377 crore public issue was open for subscription from October 9-13, with shares priced in the ₹461-485 band. Investors needed a minimum investment of ₹13,830 for one lot of 30 shares. Allotment status was finalized on October 14.
Company Background
Established in 1999, Rubicon Research has transformed from a contract development services provider to a focused pharmaceutical company. The company now develops, manufactures, and markets specialty and generic prescription products, primarily targeting the US market.
How to Check Allotment Status
On BSE:
- Visit BSE’s official website and navigate to the application status page
- Select ‘Equity’ under Issue Type, then choose ‘Rubicon Research Ltd’
- Enter your application number and PAN card details
On NSE:
- Go to NSE’s website and access ‘Equity & SME IPO bid details’
- Select ‘Rubicon Research Ltd’ from the list
- Provide your PAN card number and application number
